HIGHLIGHTS
- who: Ioannis Parodis from the Foundation Trust, United Kingdom University of Cagliari, Italy have published the article: B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools, in the Journal: (JOURNAL)
- what: This approach has recently been evaluated in patients with SLE within the frame of e_g, the BEAT Lupus and BLISS-BELIEVE trials.
- future: The prospect of bortezomib in SLE gained promise after experiments in murine lupus and reports of bortezomib use to treat allograft rejection after kidney transplantation . The prospect of obinutuzumab for the treatment of lupus nephritis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.